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Geachte decaan, geachte leden van de begeleidingscommissie, dear 
professors, dear members of the bioinformatics and systems biology 
community, dear colleagues, dear students, beste familie en vrienden, 
I am really happy and honored that you are here today to listen to my 
inaugural lecture. 
 
Een eerste zin in twee talen? De Universiteit Maastricht is er trots op 
de meest internationale universiteit van het land te zijn en natuurlijk 
is wetenschap zelf ook internationaal. Ik zal het hebben over het 
samenbrengen van kennis en daarmee ook over internationaal 
samenwerken. Een groot deel van onze studenten komt van buiten 
Nederland en veel van ons onderwijs is Engelstalig en dat geldt ook 
voor een groot deel van mijn eigen medewerkers. Veel internationale 
collega’s hebben aangegeven niet hier te kunnen zijn, maar wel graag 
online te willen zien wat ik heb gezegd. In deze rede zal ik proberen 
duidelijk te maken dat wanneer onderzoekers verschillende talen, 
verschillende begrippen, verschillende standaarden gebruiken we 
niet moeten forceren ze hetzelfde te laten doen. Maar dat we moeten 
kijken naar verbanden, naar vertalingen. Een tweetalige oratie is 
echter wat veel gevraagd. Omdat wij buitenlandse collega’s eigenlijk 
niet de kans geven Nederlands te leren doordat we ze altijd 
aanspreken in het Engels zal ik de rest van deze lezing dan ook in het 
Engels doen. 
 
In my faculty, the faculty of health, medicine and life sciences, we 
study life itself, what it means to be healthy or to stay healthy, how 
people can be healed and even what life really is, how it all works. We 
focus on human biology and on real life issues. The southern part of 
Limburg unfortunately is the least healthy region in the Netherlands. 
We study consequences of the unhealthy habits that we have here 
and in the western world in general. Things like obesity, diabetes and 
lung diseases, or on the positive side what kinds of nutrition or life 
styles are really healthy. This slide is from our website.  
 
 
 
During our Open Days we ask prospective students research 
questions like “how do we prevent the jojo effect?”. Confronting? 
Yes.., but also touching upon real life. You may consider obesity a 
luxury problem, but it also kills people and it is extremely expensive 
for our health care system. They even paint questions on the 
pavement leading to the building where I work. In these days of 
reviving student engagement you could also ask “why don’t we allow 
or even encourage our students to paint research questions on the 
streets during the rest of the year?” 
 
So, we study human biology. The problem is that biology is very 
complicated. That brings me to the first problem I want to address. 
We tend to underestimate how complicated biology really is. That 
already starts in high school; biology is considered one of the easy, 
not so technical, choices. That is probably related to the fact that we 
associate it with nice, beautiful things: flowers and butterflies. But 
look at this artist impression of a hollow road here in Limburg.  
 
 
Granted, you have to be lucky to see so many flowers at any given 
time. But even at this level; can you really think for a moment that 
the interplay between those flowers, the trees, the birds and insects 
and all these smaller things would be simple to describe?  Of course it 
isn’t. The external complexity of a single organism or the beauty of 
many of them living together often makes us hold our breath. And we 
try to freeze the image in a picture. In that way we reduce the 
complexity. Without movement and without dynamic interactions it 
feels like we understand what we look at a little bit better. However, 
it is an inherent part of life that it changes. And we want to 
understand how it changes. How our hearts beat, how we fight an 
infection, how we become happy or obese, or both… Biology also is 
complex because every single individual is incomprehensibly 
complex. We describe the human body as an interplay of organs, 
which consist of cells, again consisting of organelles which are made 
up of larger molecules like DNA and protein, and small molecules like 
sugars, fat and vitamins. 
 
 
But if you are in high school and you are interested in studying 
complex things you will rather think about studying physics or so, so 
you can go into building rockets or computers. Biomedicine is 
considered less beta and people choose it for different reasons, very 
good reasons. Our students and staff members are driven by the idea 
that they want to heal people or want to keep people healthy. They 
are good people, dedicated to a good cause. But, let’s face it, not so 
many like to think about the chemistry that makes all these living 
things do what they do. In fact for many of us “chemical” doesn’t even 
sound like it is about life. It sounds more like the stuff we make in 
smelly factories. And yet, the system below all those living things is of 
a chemical nature.  
 
 
This picture shows some of the building blocks of life like a 
biochemist would look at them. On the left in red and blue you see a 
fragment of a DNA molecule and on the right you see a protein that 
interacts with that specific fragment.  
For experts representations like this one are very relevant. They are 
important pieces in the puzzle of understanding life. If they look at a 
picture like this in detail they understand that if some of the amino 
acids in the protein are changed, the protein itself must change, 
because chemically and physically it just cannot keep the form 
needed to perform its normal function. 
 
This is just one interaction between one protein and one piece of 
DNA.  
 
 
This picture comes from a research paper that we published just a 
month ago. Martina and Susan in my group reanalyzed data from 
studies in livers from type 2 diabetic patients. Every individual blue 
rectangle is a protein like the one you saw before. And every small 
circle is a gene that is influenced by such a protein. The colors 
indicate something of what we know about those genes, the 
processes they are involved in.  
 
So here we are looking at a part of the complicated system involved 
in the development of diabetes.  If you look at it a little more you’ll 
see that these proteins in blue actually affect a lot of genes each. And 
many of these genes in the circles again are affected by more than 
one of the proteins. There even are blue lines indicating that they 
sometimes affect the genes that produce the other proteins indicated 
in the rectangles, sometimes even their own gene. Don’t forget that to 
understand any one of these lines, these interactions in the network, 
you would have to look at the real chemistry of the protein, like we 
just did in the previous picture. What changes will make it fail? Only 
then can you start to understand why somebody that has a changed 
gene might develop diabetes earlier or later. And only then can you 
decide whether any personal treatment, with a drug for instance, 
might work for one person and not for another. 
 
Real world health problems like diabetes do not just ask for 
disciplines that can deal with the inherent complexity, like graph 
theory, neural network approaches or machine learning. They also 
ask for collaboration between disciplines. What often happens is that 
researchers see that a problem extends outside the boundaries of 
their own discipline and then they tend to stop at the border. What is 
needed is that people from different disciplines work together across 
these borders. They need to challenge each other. Especially in 
medicine we are not used to that. Sometimes things that we thought 
of as facts, as foundations of what we did and believed for years, start 
to shake when looked upon from another equally scientific 
perspective. You cannot say that the problem you work on every day 
needs to be studied on the systems level and then leave it to experts 
from for instance a more mathematical discipline to solve that. That 
is because these systems approaches too have limits and only the 
domain expert knows whether these limits are reached or not. 
 
We often hope that modern research can find simple relationships 
between what is very deep in the system and what happens on the 
outside. We love simple relationships with simple consequences. This 
is about our own life after all, our own health. As a consequence we 
like to read about single genes found to be related with things as 
complex as autism. For that purpose we do a lot of so called genome 
wide association studies. Basically we ask the question “can we find 
places in the genome where people that have a different piece of DNA 
around there have a different trait, become more easily sick for 
instance?”.  
 
 
 
This picture shows what GWAS results were known about a year ago 
for 17 different traits. It includes some that are really relevant for 
this not so healthy Limburg: cardiovascular diseases and metabolic 
diseases. It shows the whole genome, all 23 chromosomes. It must 
have cost billions in research money to get all that data. The good 
thing is of course that all that data is now available for further 
research. But is it also really worth that much? These variant-trait 
relationships do not show that a specific change in the genome 
causes the trait, they show that “something around there” might do 
that. So compared with the protein-gene puzzle pieces I described 
before it is more the hint “there should be a puzzle piece here 
somewhere, try to find it”. And still… These are the things that make 
it into the newspapers. 
 
That is because we think that if we understand such things we will be 
able to do something about it. But unfortunately many of these 
findings are a bit like saying you really need nuts and bolts to build 
an engine, so very true and so very useless. We do know that such 
conclusions are oversimplifications.  We just like to believe in simple 
conclusions; it is easy to sell such an idea and it even makes actual 
products sell, superfoods for instance. Promising such outcomes even 
helps us to get research grants funded. Yet, we do know that life is 
based on a really complex system with extreme amounts of 
interactions and many possibilities to behave slightly different or 
alternatively many possibilities to respond to being pushed from the 
outside and remaining essentially unchanged. That made us redefine 
what we think health is. Health is not the absence of being sick. 
Health is the ability of that complex system to withstand many kinds 
of stress. You are not healthy if you stand upright, you are healthy if 
you remain standing upright if somebody pushes you.  That 
complexity is why we talk about systems biology. If you feel that 
biology always was complex and systems biology is just a modern 
term for biology or maybe physiology, then yes, you are right. We like 
such terms though. Because for a while they help us indicate what we 
feel is important. But they are often overused and then become just 
fashion. When that happens such terms become nice to play 
“scientific term bingo” on social media during conferences.  One way 
social media can help us to “stay real” in science. 
 
So how can we solve all that? What helps is that we get better at 
measuring things. Well to be honest, we are especially getting better 
at measuring some things. We do not learn to measure that many 
new things. What we do learn is to measure the same things quicker 
often by using micro technology. We have more and more highly 
parallel measurement technologies that measure a lot, really a lot, of 
things in parallel. This is especially true for measurements related to 
genes and the expression of genes. We can easily and affordably 
sequence your entire DNA or compare all the genes expressed in a 
tumor with that in healthy tissue.   
 
This is where another “bingo term” shows up: “big data”. Measuring 
many things means we get lots of information. We need to organize 
that data in such a way that we can use it in combination with other 
things that we know or measured.  That unfortunately sounds a lot 
simpler than it is. 
 
We tend to think about “big data” problems as related to data size. 
And yes, we have such problems, even though computer storage 
keeps getting cheaper all the time. We can in fact store astronomical 
amounts of data. Two week ago I was at the European Southern 
Observatory head quarters in Munich for a European data 
infrastructure meeting. There they work with literally astronomical 
amounts of data, and they do very complex things with that. They 
also produce very beautiful pictures like this one.   
 
 
 
But what struck me is that they told us that the growth rate of data 
that they produce is actually lower than the growth of the amount of 
computer storage you can buy for a certain amount of money.  In 
other words astronomy does not have a data storage cost problem. 
They can keep storing all the information they collect and it even gets 
cheaper. Unfortunately you cannot say the same about biology. We 
do produce ever more data at such a pace that it gets more expensive 
to store it. This picture shows that.   
 
 
The blue line shows how much hard disc storage size you can buy for 
a given amount of money over time. The yellow line shows the pace 
at which we produced new DNA data just a few years ago. The 
important thing is that that line is less steep than the blue one. That 
means that we could store that increasing amount of data year after 
year and spend less, not more money on storage. For astronomy that 
still holds. Lucky astronomers. The problem is the red line, which is 
for the new DNA sequencing technologies. That line is steeper than 
the blue line. In other words we need to spend more money on 
storage every year. And while we can learn to store in more efficient 
ways that problem will not go away. We will have to learn to 
substantially reduce the amount of data we want to keep. In other 
words we need to learn to throw things away. In the medical field 
that is problematic. We are obliged to keep all the data that might be 
relevant to evaluate medical judgments. Since we actually cannot 
keep all raw data we need a better evaluation of what is and what 
isn’t needed for that and we need rules, laws even, that are in line 
with that.  
 
 
Apart from these unsolved data volume problems there are other 
problems related to big biomedical data.  To understand that it is 
helpful to think about an actual study. Let’s take a modern one like 
we really perform them. Suppose we do a study where we want to 
find out about how our diet influences obesity. We want to 
understand why some people eat more, or why some people gain 
more weight even though they do not eat more. For that we of course 
collect information about what people really eat and about the actual 
weight changes. We probably collect a lot of other information too. 
To give just some examples that could be: blood pressure, response 
to challenges like drinking a glass of sugar water or information 
about other life style factors: “do they snack?”, “do they exercise?”, 
maybe even “are they happy?”. Like I described we know that the 
system depends on the whole interplay of small molecules like 
protein and DNA and nutrients.  Therefore, we often measure a lot of 
that as well. The expression of all the genes, thousands of metabolites 
or even the actual DNA sequence.  
If we want to analyze all that data we need to organize it. What I want 
to address is how we should do that on a larger scale; for all 
biomedical studies in Europe for instance. There is an increasing 
notion that research results from government or EU funded research 
should be open. After all the research was paid for by the taxpayer. 
Why would the taxpayer pay for the same data again?  But that 
assumes that we put the data somewhere where you can find it and 
from where you can really reuse it. Funders will in fact make that 
obligatory. Not just because that is efficient, not just because we can 
all do more if we can all use all the data that was produced before, 
but also because that is how science is supposed to work. You should 
be able to verify the findings that were published. And for that you 
need the data. That leads to better analysis and it also helps to 
prevent fraud. Unfortunately, that is needed too. There is an 
international movement to make data FAIR. Where FAIR is an 
acronym. F is for Findable. A is for Accessible, because if you know 
where it is but you don’t get access it is a bit like a locked cookie jar. I 
is for Interoperable, because you want to be able to use it in 
combination with other data. Finally R is for Reusable.  The latter for 
instance means that you need to know how exactly the data was 
produced -- something we call data provenance -- and of course you 
also need a license that allows you to reuse it. 
I spend a lot of my time on organizing interoperability. It means for 
instance that you need to know that things that are present in 
different resources actually are the same. Now it might seem to you 
that the easy way to do that would be to just name them the same. 
But unfortunately that is not always possible. That is in part because 
scientists are humans too, and where it would help if we all started to 
speak the same language that is just not going to happen. So even if 
working with one standard would be beneficial we need to be 
realistic and accept that some people use inches while others use 
common sense (ehhm centimeters). Apart from that different experts 
use different terms often for a reason. Or in one field of expertise you 
may need more granularity for some things and less for some others. 
Some researchers may just need white and black while others need 
fifty shades of gray. We need ways to get exact descriptions of what 
people mean using vocabularies and ontologies that are common in 
their own field. We often need to extend these vocabularies and 
ontologies. By the way, an ontology is a neat scientific way to 
describe something like a tree. An ontology used to describe an 
actual tree would know that the tree has branches and the branches 
have twigs and the twigs have leaves. That is not even all. Consider a 
leave that has fallen from the tree in autumn. Is that still a leave? For 
many purposes it is, but not for all. If you are looking at 
photosynthesis for instance you might not want to consider that 
fallen leave a leave. In this context we say science uses lenses to look 
at how we describe things, not just which things we consider equal, 
but also when we consider them equal and when not. We work with 
some computer science groups in the UK and at the VU to make these 
lenses really work in data science. 
 
My colleague professor Mons, who is present here, focuses on the 
whole FAIR problem and encourages the development of an 
ecosystem of FAIRports. Building a useful FAIRport system will be 
whole lot easier however if we organize the data in a sensible way in 
the first place.  
 
 
 
I created this diagram for the European data meeting at the Southern 
Observatory that I mentioned before. It is far less beautiful than the 
nebula picture from that observatory, but worth a look. First of all 
you should realize that all the arrows point downwards. At the top 
level are the FAIRports for the different domains. They have study 
capturing resources that are specific for a domain. The nutritional 
resource for instance knows that we are interested in diets and we 
typical perform cross over studies and do challenge tests. We are 
building such resources in international collaborations. They are, or 
should be, linked to the repositories on the left; the kind of resources 
that we typically use for big parallel datasets: they hold all the public 
genomics data, all the metabolite measurements, and so on. That box 
has a green border because to a large extend it is already there. The 
resources on the center right unfortunately are only in early stages of 
development. They are supposed to hold all “the other” things that 
researchers measure. Meaning they always need to contain a 
combination of what was measured, and how, and what the result 
was. The bottom part literally is closer to home. This is a repository 
like Maastricht University now develops to allow researchers to store 
and expose their own data. That is important and needed. But like I 
said, all the arrows in this diagram point downwards, and that is for a 
reason. If you want to expose your research data for reuse, and you 
for instance want to have it cited, then you need to make sure that 
the relevant parts are in the more international technology or 
research field specific resources at the higher levels. You need to 
make sure that technology related data is described in the correct 
way, linked from these study descriptions at the top and put in the 
correct repository on the left. Finally all these other things you 
measure should go into domain specific resources on the right that 
are now being developed. That means Maastricht University does not 
just need a big local resource.  What we do need too are trained data 
specialists that actually know about these other resources, especially 
the technology specific ones on the left, since these are used in 
multiple research fields. The researchers themselves should know 
about the resources specific for their own field. Unfortunately both 
these conditions currently are not met. Without that building your 
own data repositories might create more problems than it solves. 
 
 
So far I have talked about the complexity of the biological system that 
underlies health and disease and described it as a large puzzle. I have 
indicated that what we understand and measure about the molecules 
and the interactions between those molecules can provide us the 
pieces of the puzzle. And I have described that we need to organize 
these pieces of information so that we can reuse them. The title of my 
lecture is “puzzling with the pathways of life”. So where are the 
pathways? Well let me show you one.  
 
 
This is what biologists call a pathway. It shows an important 
regulatory process that in a liver cell activates a larger set of proteins. 
In fact you can see the liver cell itself. The double line around most of 
it is easily understood by biologists as the cell wall and the proteins 
that are drawn embedded in that wall thus are likely pumps that 
transfer things in or out the cell (like the glucose transporter on the 
top left), or receptors that bring a hormone signal to the inside (like 
the insulin receptor on the top right) or the opposite like the blue, 
green leptin exporter a bit right from the glucose transporter. Such a 
pathway thus holds a lot of information that is intuitively understood 
by an expert. This specific pathway was used in the diabetic liver 
study that I talked about when I showed you the network of blue 
regulating proteins affecting many genes. The green right half boxes 
show that the regulation of a gene was significantly different in the 
diabetic patients, the blue-red color shades to the left of that show 
whether that change was up or down. Pathways thus help you 
understand the process and assist in understanding the data. In fact 
they are a means to combine what we measured with what we 
already know. If you would work with that pathway on a computer 
screen you could also just click one of the many molecules is the 
pathway and get more information about it from various databases. 
For people from the 21st century that might not come as a big 
surprise. You are used to having pages with information showing up, 
and being clickable. But this is what the Internet was invented for 
originally. Bring all that information to the fingertips of the scientists. 
A lot of knowledge actually is available in different resources on the 
Internet. You can for instance easily and even fully automatically find 
information about genes, proteins and their relation with diseases. 
The GWAS resource that I showed before showing all the known 
variant-trait relationships is an example of that too. We created 
WikiPathways, in collaboration with another bioinformatics group 
at the University of San Francisco. WikiPathways a wiki, like 
Wikipedia. Everybody can contribute to it.  
 
 
It has specific tools that make it easy to edit pathways and to use 
them to do the kind of analysis I just showed. We have around 2000 
of such pathways and there are ten thousands of edits on these. So 
yes, we do get the information directly from the experts. Adding that 
information plus the evidence, for instance as references to the 
original scientific papers is very useful because it provides a context 
for research and because it helps solve the problem that all these 
things we know about are hidden in the literature and are not readily 
available in a computer readable or even in a comprehensive human 
readable form.  
It is not just us or just WikiPathways. The scientific community as a 
whole has done enormous amounts of database curation, the monks 
work. I went to a Biocurator conference once and was surprised to 
see hundreds of people there alone that just read and evaluate 
papers and improve databases every day. Yet, when we talk about 
teaching our students academic skills about how to “find knowledge” 
we only teach them how to search the literature. Not where the best 
comprehensive resources are, how you search them, how you 
evaluate how good they are. We also do not teach them how to use 
automated programmatic methods to find that data. Today we all 
have smart phones with more computing power than what we used 
to bring people to the moon but we still only learn our students how 
to produce new data and not how to experiment with things we 
already known. 
 
Let me finish with another real world example that we very recently 
studied. As you may know Vitamin D is considered one of the more 
critical micronutrients, we are not really sure we always get enough 
of that especially at older age. That in it self leads to ideas about 
precision medicine. If older people really need more, we should come 
up with age dependent advices.  Genetic variations influence how we 
convert Vitamin D in different forms. That is important for how much 
each of us needs individually.  
We asked ourselves what Vitamin D really does on a systems level. 
My personal understanding is that it is a kind of spring hormone. 
When the sun starts to be more powerful in spring it lets you produce 
more Vitamin D. That Vitamin D then targets a lot of genes involved 
in a lot of processes that all make you more active. That maybe makes 
you want to do the fun things many animals do in spring.  Vitamin D 
also plays an important role in prostate cancer and since there were 
some interesting datasets available we decided to look at these. This 
diagram shows what we did.  
 
We took two datasets: one about expression of normal genes, the 
other about expression of small regulatory gene products. We did 
pathway analysis with the first set and found a number of cell cycle 
related and even a number of cancer related pathways that were 
changed in prostate cancer cells that were treated with Vitamin D. 
We built a large network out of these cell cycle related pathways 
and… we extended that with neighboring proteins and genes from 
other resources. In that way we were able to find a very large fraction 
of the regulated genes in a single network. Finally we combined that 
with the miRNA data and looked for active parts of the network. The 
parts that we think might be the corner pieces of the puzzle.  
  
 
The next picture gives an impression of the combined network, even 
before we extended that. Yes, it gets big. Vitamin D really does a lot of 
things. Note the number of blue, down regulated proteins to the very 
right. The left part shows that these actually appear in the overlap 
between cell cycle and DNA replication.  That is a core aspect of cell 
division and thus really relevant for cancer.  
 
The final slide shows some of what we think of as the corner pieces 
for this specific puzzle. Small gene products that influence genes in 
the pathways we found (the diamonds) or regulated genes known to 
be directly connected to these pathways (the ellipses). All these 
genes are affected by these central miRNAs. Of course such an end, 
never really is the end. We now need to evaluate this further, using 
yet other types of information and we need to check it with cancer 
specialists to see whether we can use this for therapeutic purposes 
already. It may also help us to better understand what Vitamin D 
does, and how much of that we really need.  
 
I deliberately showed these four more complicated slides at the very 
end. I wanted you to understand what I mean by combining things. 
But I wanted you to have some idea of what we combine first. 
Professor Gert-Jan van Ommen director of the Dutch Biobanking 
initiative BBMRI-NL was once asked what the focus is of 
bioinformatics research in the Netherlands. He said: “we focus on 
everything”. Well… We focus on combining everything. Mostly we 
leave it to others to find the pieces. And actually, we even leave 
building the larger pieces, the pathways mainly to others too. What 
we try to do is combine all that to help solve real biological puzzles. 
 
There are quite a few challenges that remain. We for instance want to 
get directionality in pathways right. So we can find drugs that hit 
things that hit things that are being hit by current drugs. Or we can 
find combinations of drugs that will work better than current single 
treatments. We also want to integrate all that ongoing genetic 
variation work in our pathway approach more and we want to link to 
the modeling world where people calculate how fast processes work. 
On all these three things we currently have PhD students working. 
And all that work will play an important role in Maastricht’s new 
Center for Systems Biology MaCSBio. 
 
To do this work you have to work with many, many people from 
many different communities. That leads to a long list of people with 
whom I collaborate. People without whom this work would just not 
have been possible. Many of you were invited because you were 
important one way or another for the work I described or for the 
personal development that allowed me to do this, or just for the 
realization that life is fun and worth living, and for me that includes 
worth trying to understand it. I would need another 45 minutes to 
thank you all. So I won’t. Even though some of you are very close to 
me. I do want to mention all the current and past members of my 
own group because they actually did the work that made this 
possible. I want to mention just two other people specifically. The 
late professor Bert Bijsterbosch from Wageningen University. During 
my own masters I tried to use irreversible thermodynamics 
approaches that I learned from Hans Westerhoff’s early papers to 
describe why the lab research I had tried to do could never work. 
Professor Bijsterbosch’s comment was: “you simplified the approach 
so far that it was no longer an irreversible process, but in doing so 
you actually proved your point.” That remark made so early in my 
career always stayed with me. Make your puzzle as complicated as 
needed, but simplify it again to reach a solution. The other one I want 
to mention is professor Jos Smits. He was the one that said: “Chris 
you understand both about biology and about computers and we 
need a bioinformatics group. What do you think?” When I asked how 
long I could think about that he said: “we order tickets to fly to Palo 
Alto next Monday” so that’s early enough. Jos, I never regretted the 
choice I made at that time. I do think this university and science in 
general would benefit if more people made such career changes. I 
also think universities should be more supportive of that.  
 
I want to finish with this. I have shown that we currently develop a 
lot of infrastructure in the biomedical world that is badly needed for 
research. That is all done in temporarily funded projects. That 
infrastructure is then used to give away data for free because that is 
important. However, such infrastructure needs continuous support 
and development. Now giving away things for free is not going to 
make you a lot of money. Since freely available knowledge and data is 
what is needed to bring science forward the consequence is that we 
need more long time support for that. 
 
Ik heb gezegd. 
 
